Skip to Content

Baxter International Inc

BAX: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$86.00ZgzkntKwqdfcmm

Supply Chain Pressures Roil Baxter's Near-Term Outlook; Shares Cheap Even After FVE Cut

While narrow-moat Baxter appeared to roughly meet expectations in the second quarter, supply chain problems cut into its near-term outlook and sent the shares down about 10% in early trading. We are reducing our 2022 and 2023 expectations based on the headwinds Baxter's operations are facing, which has cut our fair value estimate to $85 per share from $90. The shares appear significantly undervalued at recent levels.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of BAX so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center